ANIK
Anika Therapeutics IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$193.60M
P/E Ratio
—
EPS
$-0.79
Beta
0.16
52W High
$16.24
52W Low
$7.87
50-Day MA
$14.31
200-Day MA
$10.70
Dividend Yield
—
Profit Margin
-9.52%
Forward P/E
106.38
PEG Ratio
10.61
About Anika Therapeutics Inc
Anika Therapeutics, Inc., is a joint preservation company in the United States, Europe, and internationally. The company is headquartered in Bedford, Massachusetts.
Fundamentals
| Revenue (TTM) | $116.26M |
| Gross Profit (TTM) | $68.12M |
| EBITDA | $-6.86M |
| Operating Margin | -18.50% |
| Return on Equity | -7.85% |
| Return on Assets | -4.14% |
| Revenue/Share (TTM) | $8.22 |
| Book Value | $10.33 |
| Price-to-Book | 1.48 |
| Price-to-Sales (TTM) | 1.67 |
| EV/Revenue | 1.568 |
| EV/EBITDA | 8.20 |
| Quarterly Earnings Growth (YoY) | -50.50% |
| Quarterly Revenue Growth (YoY) | 13.20% |
| Shares Outstanding | $13.31M |
| Float | $11.25M |
| % Insiders | 5.93% |
| % Institutions | 93.97% |
Historical Volatility
HV 10-Day
150.00%
HV 20-Day
106.18%
HV 30-Day
88.14%
HV 60-Day
75.89%
HV Rank
87.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($17.50 target)
1
Strong Buy1
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026